Head Of Research Development At Convatec News Today : Breaking News, Live Updates & Top Stories | Vimarsana

30 Technology s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications

30 Technology s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomNorth lanarkshireTechnologysyd hannaDivakar ramakrishnanChris woodChris welshContactsamber fennellSyd hannaTechnology clinically validated antimicrobial nitric oxideplatformLucy featherstoneconsilium strategic communicationsRoyal college of surgeons edinburghProfessor at imperial college londonConvatec group plcHead of research development at convatecGoodwin procter

Investegate |30 Technology Announcements | 30 Technology: 30 Technology s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications

Investegate announcements from 30 Technology, 30 Technology’s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications

City ofUnited kingdomNorth lanarkshireDivakar ramakrishnanChris woodSyd hannaLucy featherstoneChris welshAmber fennellRoyal college of surgeons edinburghConvatec group plc for several applicationsHead of research development at convatecTechnology clinically validated antimicrobial nitric oxideplatformConvatec group plcGoodwin procterTechnology clinically validated antimicrobial nitric oxide platform

Convatec acquires anti-infective nitric oxide technology platform

Convatec acquires anti-infective nitric oxide technology platform

United kingdomSyd hannaDivakar ramakrishnanHead of research development at convatecConvatec group plcAdvanced wound careChief technology officerAdvanced woundGroup executive director

Convatec secures a highly innovative technology platform in the anti-infective space

Convatec secures a highly innovative technology platform in the anti-infective space• Acquisition of innovative anti-infective nitric oxide technology• Convatec will explore application of this highly innovative technology across business categories• Convatec well positioned to commercialise this tech.

United kingdomSyd hannaDivakar ramakrishnanHead of research development at convatecConvatec group plcAdvanced wound careGroup plcChief technology officerAdvanced woundGroup executive director